Nasdaq Biotechnology Ishares ETF (IBB)

$141.30 +1.07 (0.76%)
Market Cap N/A
Revenue (ttm) N/A
Net Income (ttm) N/A
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 552,023
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts N/A
Price Target N/A

Latest News on IBB

How tariffs could impact pharma and early-stage healthcare investments

Feb 3, 2025, 6:43 PM EST - 18 days ago

How tariffs could impact pharma and early-stage healthcare investments

XLV

Can Health Care ETFs Aid Your Portfolio?

Feb 3, 2025, 7:49 AM EST - 19 days ago

Can Health Care ETFs Aid Your Portfolio?

ARKG HTEC IYH SPY VHT XBI XLV

Biotech walks a 'tightrope' amid unclear funding, regulations

Jan 30, 2025, 7:06 PM EST - 22 days ago

Biotech walks a 'tightrope' amid unclear funding, regulations

DCTH ELVN

Top 5 Cancer Pharma Stocks With Strong Risk/Reward In 2025

Jan 13, 2025, 6:10 PM EST - 5 weeks ago

Top 5 Cancer Pharma Stocks With Strong Risk/Reward In 2025

ABBV AMGN AZN BNTX FBCG GILD GSK

iShares Biotechnology ETF: Playing Defense

Dec 10, 2024, 1:33 PM EST - 2 months ago

iShares Biotechnology ETF: Playing Defense

Mizuho's Jared Holz on what Trump's FDA pick means for biotech innovation

Nov 25, 2024, 6:44 PM EST - 3 months ago

Mizuho's Jared Holz on what Trump's FDA pick means for biotech innovation

HIMS LLY MRNA NVO PFE

Health care stocks jump on Trump's nominee for FDA head

Nov 25, 2024, 6:22 PM EST - 3 months ago

Health care stocks jump on Trump's nominee for FDA head

HIMS LFMD MRNA PFE

Final Trade: Euro, IBB, SMH, NEM

Nov 20, 2024, 6:21 PM EST - 3 months ago

Final Trade: Euro, IBB, SMH, NEM

SMH NEM

Final Trade: West Pharma, Cameco, iShares Biotechnology ETF and Applied Digital Corp

Nov 15, 2024, 6:54 PM EST - 3 months ago

Final Trade: West Pharma, Cameco, iShares Biotechnology ETF and Applied Digital Corp

APLD CCJ WST

IBB: A Near-20x P/E Is Historically Pricey, Technical Trends Neutral

Oct 14, 2024, 7:36 AM EDT - 4 months ago

IBB: A Near-20x P/E Is Historically Pricey, Technical Trends Neutral

Biotech Stocks Are Showing Signs of Life. Why the Rally Could Continue.

Aug 30, 2024, 5:34 PM EDT - 6 months ago

Biotech Stocks Are Showing Signs of Life. Why the Rally Could Continue.

GILD XBI

Biotech stocks will get a tailwind from rate cuts, says Stempoint's Michelle Ross

Aug 12, 2024, 4:25 PM EDT - 6 months ago

Biotech stocks will get a tailwind from rate cuts, says Stempoint's Michelle Ross

LLY XBI

Analyst is 'extremely bullish' on biopharma

Jul 30, 2024, 3:25 PM EDT - 7 months ago

Analyst is 'extremely bullish' on biopharma

MRK PFE

iShares Biotechnology ETF: Significant Upside Potential As Sector Gains Momentum

Jul 28, 2024, 12:25 PM EDT - 7 months ago

iShares Biotechnology ETF: Significant Upside Potential As Sector Gains Momentum

Biotech Stocks 2024 Second Half Outlook - Buy Biotechs

Jul 9, 2024, 7:00 AM EDT - 8 months ago

Biotech Stocks 2024 Second Half Outlook - Buy Biotechs

XBI

For Biotech Stocks To Move Higher, This Must Move Lower

May 13, 2024, 9:00 AM EDT - 10 months ago

For Biotech Stocks To Move Higher, This Must Move Lower

XBI

This weight-loss ETF has performed well in its first five months. How does it compare with cheaper alternatives?

Apr 10, 2024, 9:27 AM EDT - 11 months ago

This weight-loss ETF has performed well in its first five months. How does it compare with cheaper alternatives?

AMGN ASND CYTK DXCM EW HRTS IHE

Biotech's Next Gold Rush: Weight-Loss Drugs

Apr 2, 2024, 4:56 PM EDT - 11 months ago

Biotech's Next Gold Rush: Weight-Loss Drugs

LLY NVO

Catch The Medical Breakthroughs With The IBB ETF

Mar 28, 2024, 2:01 AM EDT - 11 months ago

Catch The Medical Breakthroughs With The IBB ETF

IBB: Let It Rest

Mar 26, 2024, 4:46 AM EDT - 11 months ago

IBB: Let It Rest

Why Biotech Stocks May Be Ready For A Recovery

Mar 9, 2024, 3:59 AM EST - 1 year ago

Why Biotech Stocks May Be Ready For A Recovery

BBH XLV

Navigating the big run in biotech

Feb 15, 2024, 1:44 PM EST - 1 year ago

Navigating the big run in biotech

XBI

Health care's underperformance last year sets it up well for 2024, says Mara Goldstein

Feb 8, 2024, 7:34 AM EST - 1 year ago

Health care's underperformance last year sets it up well for 2024, says Mara Goldstein

XLV

Healthcare In 2024: Navigating The Biopharma Bull Run

Jan 17, 2024, 11:22 PM EST - 1 year ago

Healthcare In 2024: Navigating The Biopharma Bull Run

FHLC IYH PPH VHT XBI XLV

Equity CEFs/ETFs: Top Picks For 2024 - Part II

Jan 5, 2024, 11:01 AM EST - 1 year ago

Equity CEFs/ETFs: Top Picks For 2024 - Part II

AIO AIQ BIB DIG EOI ETW EXG

Dr. Scott Gottlieb talks Big Pharma's buying spree

Dec 27, 2023, 4:26 PM EST - 1 year ago

Dr. Scott Gottlieb talks Big Pharma's buying spree

XBI

Wedbush's Laura Chico talks biotech investing in 2024

Dec 26, 2023, 5:21 PM EST - 1 year ago

Wedbush's Laura Chico talks biotech investing in 2024

EWTX NBIX VRDN XBI

Buy or bail on biotech: Here's what you need to know

Dec 26, 2023, 1:40 PM EST - 1 year ago

Buy or bail on biotech: Here's what you need to know

XBI

Biotech Stocks Are Breaking Out—and They Show No Sign of Slowing Down

Dec 26, 2023, 11:30 AM EST - 1 year ago

Biotech Stocks Are Breaking Out—and They Show No Sign of Slowing Down

XBI

Wells Fargo's top pharma picks for 2024

Dec 15, 2023, 5:33 PM EST - 1 year ago

Wells Fargo's top pharma picks for 2024

ABBV AMGN BIIB LLY REGN VRTX

We see Big Pharma going after smaller biotechs in 2024, says Jefferies' Michael Yee

Dec 15, 2023, 10:00 AM EST - 1 year ago

We see Big Pharma going after smaller biotechs in 2024, says Jefferies' Michael Yee

MRK MRNA PFE

IBB: Technicals And Risk Metrics Point To Lower Prices (Technical Analysis)

Nov 23, 2023, 1:39 AM EST - 1 year ago

IBB: Technicals And Risk Metrics Point To Lower Prices (Technical Analysis)

IBB: Targeting A Buy Point Heading Into Year-End

Nov 21, 2023, 9:11 PM EST - 1 year ago

IBB: Targeting A Buy Point Heading Into Year-End

How to Find the Best Biotech ETFs

Oct 30, 2023, 4:52 PM EDT - 1 year ago

How to Find the Best Biotech ETFs

ARKG XBI

Goldman Sachs' Chris Shibutani talks his top biotech picks including Eli Lilly and Pfizer

Sep 29, 2023, 5:43 PM EDT - 1 year ago

Goldman Sachs' Chris Shibutani talks his top biotech picks including Eli Lilly and Pfizer

LLY PFE XBI

Biopharma Bounce-Back: From Policy Pains To Profitable Plains

Sep 8, 2023, 12:03 AM EDT - 1 year ago

Biopharma Bounce-Back: From Policy Pains To Profitable Plains

GILD HQH ILMN IQV LABU MRK OHI

IBB: The Illness Of Idiosyncratic Risk

Aug 30, 2023, 12:47 PM EDT - 1 year ago

IBB: The Illness Of Idiosyncratic Risk

Biotech Continues To Struggle Against The Broad Market, IBB Remains A Hold

Jun 15, 2023, 5:51 PM EDT - 1 year ago

Biotech Continues To Struggle Against The Broad Market, IBB Remains A Hold

The Private Domestic Sector Prints A $130B Surplus In May Pointing To Better Markets In June

Jun 11, 2023, 5:24 AM EDT - 1 year ago

The Private Domestic Sector Prints A $130B Surplus In May Pointing To Better Markets In June

DIA

Final Trades: Abbvie, Thermo Fisher & more

Apr 5, 2023, 1:57 PM EDT - 2 years ago

Final Trades: Abbvie, Thermo Fisher & more

ABBV TMO

Biotech's Bearish Turn In 2023, But Eyeing Bullish Seasonal Trends In IBB

Mar 28, 2023, 1:35 PM EDT - 2 years ago

Biotech's Bearish Turn In 2023, But Eyeing Bullish Seasonal Trends In IBB

IBB: Biotechnology Securities Might Be Getting More Attractive As Recession Fears Loom

Mar 28, 2023, 7:31 AM EDT - 2 years ago

IBB: Biotechnology Securities Might Be Getting More Attractive As Recession Fears Loom

The Fall Of SVB: What It Means For Healthcare Startups

Mar 16, 2023, 3:51 PM EDT - 2 years ago

The Fall Of SVB: What It Means For Healthcare Startups

BBC BBH FBT IHE IHF IHI IYH

Regional banks pace decliners, as biotech deals lift Seagen and Provention Bio

Mar 13, 2023, 11:17 AM EDT - 2 years ago

Regional banks pace decliners, as biotech deals lift Seagen and Provention Bio

KRE XBI

SVB fallout: The impacts on the biotech sector

Mar 13, 2023, 9:59 AM EDT - 2 years ago

SVB fallout: The impacts on the biotech sector

SIVB XBI